Literature DB >> 8100670

Molecular variation in Leishmania.

S F Moody1.   

Abstract

The surface coat of the protozoan parasite Leishmania affords remarkable protection in the harsh environments encountered within the insect vectors and vertebrate hosts. It also provides specificity for the interaction of these parasites with the cells in the sandfly gut and with the human macrophage. Surprisingly few molecules have been identified on the Leishmania surface. The major surface molecules of both promastigotes and amastigotes are the glycoconjugates lipophosphoglycan and a glycoprotein of approximately 63 kDa. These major surface molecules vary structurally between Leishmania species and throughout the life-cycle of the parasite. In addition to these major glycoconjugates, Leishmania produce a number of less abundant surface molecules, including a family of glycosyl-inositol phospholipids, the Promastigote Surface Antigen-2 complex of glycoproteins and a glycoprotein of M(r) 46,000. These molecules share the common feature of attachment to the plasma membrane via glycosylphosphatidylinositol lipid anchors. Leishmania also release molecules from their surface in a species specific manner. In this review we will examine the molecular variation of these molecules and their biological importance. We will also discuss the potential of these molecules as targets for chemotherapy and as candidate vaccines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100670     DOI: 10.1016/0001-706x(93)90029-b

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycans.

Authors:  Olga V Sizova; Andrew J Ross; Irina A Ivanova; Vladimir S Borodkin; Michael A J Ferguson; Andrei V Nikolaev
Journal:  ACS Chem Biol       Date:  2011-04-11       Impact factor: 5.100

2.  Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.

Authors:  H Charest; G Matlashewski
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

3.  IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.

Authors:  Pedro J Alcolea; Ana Alonso; Adriana Esteban; Paz Peris; Alberto Cortés; Juan A Castillo; Vicente Larraga
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

4.  Leishmania infantum UBC1 in Metacyclic Promastigotes from Phlebotomus perniciosus, a Vaccine Candidate for Zoonotic Visceral Leishmaniasis.

Authors:  Jaime Larraga; Pedro J Alcolea; Ana M Alonso; Luis T C Martins; Inmaculada Moreno; Mercedes Domínguez; Vicente Larraga
Journal:  Vaccines (Basel)       Date:  2022-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.